Harvard Bioscience Inc HBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/20/24 EDT
3.27quote price arrow down-0.10 (-2.97%)
Volume
61,900
52 week range
3.25 - 6.20
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.27
  • 52 Week High6.20
  • 52 Week High Date06/23/23
  • 52 Week Low3.25
  • 52 Week Low Date05/20/24

Key Stats

  • Market Cap142.015M
  • Shares Out43.43M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-38.88

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.27
  • 52 Week High6.20
  • 52 Week High Date06/23/23
  • 52 Week Low3.25
  • 52 Week Low Date05/20/24
  • Market Cap142.015M
  • Shares Out43.43M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-38.88

RATIOS/PROFITABILITY

  • EPS (TTM)-0.20
  • P/E (TTM)-16.12
  • Fwd P/E (NTM)15.00
  • EBITDA (TTM)4.924M
  • ROE (TTM)-12.20%
  • Revenue (TTM)106.787M
  • Gross Margin (TTM)58.52%
  • Net Margin (TTM)-8.18%
  • Debt To Equity (MRQ)51.75%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harvard Bioscience Inc

Profile

MORE
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and...
James Green
Chairman of the Board, President, Chief Executive Officer
Jennifer Cote
Chief Financial Officer, Treasurer
Address
84 OCTOBER HILL RD
Holliston, MA
01746
United States

Top Peers

SYMBOLLASTCHG%CHG
RPTX
Repare Therapeutics Inc
3.48-0.07-1.97%
CTMX
CytomX Therapeutics Inc
1.92+0.03+1.59%
SPRO
Spero Therapeutics Inc
1.56-0.03-1.89%
RIGL
Rigel Pharmaceuticals Inc
0.9549+0.0045+0.4735%
MCRB
Seres Therapeutics Inc
0.949+0.0291+3.1634%